Hong Kong Stock Market Volatility and Key Developments

Keep up with market news and trends on East Money, and choose East Money Securities for a one-stop account opening and trading service.
The Hong Kong stock market is experiencing rapid changes! This morning, the market saw increased volatility, with significant drops early on, but these were quickly reversed. On the trading front, there were several unexpected developments. Firstly, Meituan saw a reduction in holdings. According to the latest disclosure from the Stock Exchange, Meituan co-founder, executive director, and senior vice president Mu Rongjun sold 2 million shares at 171.


8055 yuan per share on September 30th, cashing out approximately 344 million yuan. After the reduction, his stake dropped from 1.06% to 1.02%, still holding about 56.312 million shares. Secondly, oil and gas stocks made an unexpected rise. China Oil and Gas Holdings increased by 52.08%, Yanchang Petroleum International by 6.33%, China Oilfield Services by 2.71%, and China National Offshore Oil Corporation by 1.


91%. Overnight, international oil prices also surged due to tensions in the Middle East. Thirdly, the real estate market saw a blockbuster. The new development ‘Sky Palace’ by Sun Hung Kai Properties in Kai Tak ended its first round of ticket sales yesterday (3rd), with preliminary estimates showing over 29,000 property purchase intent registrations. With 204 units sold at the first round price list, it was oversubscribed by more than 141 times.


Fourthly, the Financial Times cited sources stating that under the advancement of the US ‘Biosafety Act’, WuXi AppTec has sold its cell and gene therapy manufacturing division, WuXi Advanced Therapies, which operates four laboratories and production facilities in Philadelphia. Additionally, sources revealed that WuXi Biologics is working with advisors to assess market interest in some of its European production facilities.


WuXi AppTec and WuXi Biologics also saw significant gains.



The Hong Kong stock market took off again this morning, with the dual engines of securities and real estate stocks taking flight once more. Mainland Chinese securities stocks in Hong Kong continued to rise, with Zhongzhou Securities surging over 30%, Shenwan Hongyuan up 22%, and China Merchants Securities, Everbright Securities, China Galaxy Securities, and Guolian Securities all up over 15%. Hong Kong-listed domestic real estate stocks also rose, with Agile Property, Shimao Group, Kaisa Group, and China Aoyuan all up over 10%, and Sunac China up over 8%.


The three major indices also turned strong again. It is noteworthy that this trend occurred against the backdrop of a majority of Chinese concept stocks being sold off last night. The NASDAQ Golden Dragon China Index closed down 2.4%, moving away from its highest position since February last year. The China Technology Index ETF (CQQQ) closed down 2.9%, the China Internet Index ETF (KWEB) closed down 3.


1%, and the FTSE China 3x Long ETF (YINN) fell 7.4%, while the FTSE China 3x Short ETF (YANG) rose over 7%.



The FTSE A50 futures night session initially fell by 2%, but later closed down by 0.41% at 14,928.00 points. Notably, RONDHL CHINA ETF (DRAG) closed down by 0.63% on its first day of trading in the United States. Analysts believe that the current volatility may be the true beginning of a reversal. Firstly, there is still a significant amount of overseas capital that needs to establish positions, but they are also waiting for a correction opportunity; secondly, extreme emotional exuberance is obviously not sustainable, which is common sense; thirdly, without fundamental support, the stock market, after rapid bubble formation, will most likely end in chaos. Therefore, this adjustment is also the beginning of a healthy and sustained rise.


From a market perspective, there are four sudden developments worth noting. The first is share reduction. According to the latest disclosure from the Stock Exchange, Meituan’s co-founder, executive director, and senior vice president, Mu Rongjun, reduced his holdings by 2 million shares at a price of 171.8055 yuan per share on September 30, cashing out approximately 344 million yuan. After the reduction, his stake decreased from 1.


06% to 1.02%, still holding about 56.312 million shares. In fact, recently, both Hong Kong and A-shares have seen an increase in share reduction announcements. Meituan’s stock fell nearly 4% in the morning, which may be the main force behind the Hang Seng Tech’s morning decline. The subsequent narrowing of the decline also shows that the market’s current support is still strong.



The second is oil. Due to concerns about an escalation of conflict in the Middle East leading to supply disruptions, especially fears of Israel attacking Iran’s oil infrastructure, oil prices have risen for three consecutive days, marking the longest period since August. US oil prices once surged by 5.5%, approaching $74, while Brent oil closed up by 5%, breaking through $77, both reaching their highest levels in over four weeks.


In today’s morning session, China Oil and Gas Holdings rose by 52.08%, Yanchang Petroleum International increased by 6.33%, China Offshore Oilfield Services rose by 2.71%, and China National Offshore Oil Corporation increased by 1.91%. If the situation continues to be tense, the oil and gas stocks that have been lagging behind may become the target of speculation when the A-shares open next week.



The third is the real estate market. New World Development’s new project ‘Sky Palace’ in Kai Tak received over 29,000 for the first round of sales yesterday (3rd), with an estimated 204 units released at the initial price list, resulting in an oversubscription of more than 141 times. From some mainland reports, the ‘Golden September and Silver October’ has also heated up quickly, with Shenzhen once again seeing ‘daylight discs’.


The fourth is a significant change in the pharmaceutical sector’s benchmark ‘WuXi AppTec’. The Financial Times cited sources stating that under the advancement of the US ‘Biosafety Act’, WuXi AppTec has sold its cell and gene therapy manufacturing division, WuXi Advanced Therapies, which operates four laboratories and production facilities in Philadelphia.
Additionally, sources have revealed that WuXi Biologics is collaborating with consultants to evaluate market interest in some of its European production facilities.


The stock prices of WuXi AppTec and WuXi Biologics continue to rise today. Ultimately, analyzing the overall market trend must focus on the securities sector, which has already become a bull market during the National Day holiday, and this sector is also a barometer for the bull market. It can be said that if this sector begins to consolidate, the adjustment will truly arrive. The A-share market is no different; if CITIC Securities and Orient Wealth show signs of fatigue, the market may be approaching a period that requires consolidation.


Experience the new and innovative investment research assistant immediately. (Source: Securities Times)



Leave a Comment

Your email address will not be published. Required fields are marked *